Creating a new generation of small molecule serine protease inhibitors

News

Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed Transaction

22 June 2016 Read more...

Carbylan Therapeutics Inc. and KalVista Pharmaceuticals Ltd. enter into Share Purchase Agreement

15 June 2016 Read more...

Registered Office: Building 227, Tetricus Science Park, Porton Down, SP4 0JQ, United Kingdom Registered in England. Registered No: 07543947